Delivery Order SPE2DB24D3015-SPE2DB26FFWWQ
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $28,074.21 on September 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $34,374.97 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count units) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical procurement executed under competitive procedures. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $7,796.69. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $5,646.47. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,692.22 for Myrbetriq ER 50 mg tablets (90-count supply) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $13,864.26 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count). The contract is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (30-count units) valued at $7,441.72. This is a firm fixed-price, non-set-aside contract with a completion deadline of August 7, 2025, and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $25,697.77 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,964.22 to AmerisourceBergen Drug Corp for supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed price contract. This non-set-aside delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.51 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply). This firm fixed-price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery at its corporate office location. This delivery order is issued under...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWWQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,940.34 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its broader healthcare solutions portfolio serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. Through this contract framework, AmerisourceBergen Drug Corp provides medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's established capability to meet substantial federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 11/5/25 |